Ask a Fool: Is Gilead Sciences, Inc. a Sell?
In this video, as part of The Motley Fool's "Ask a Fool" series, health-care analyst David Williamson takes a question from a Fool reader, who asks:
Gilead Sciences seems to be on a down trend. Is there any specific reason, or should I just hold firm?
Our top stock for 2014
There's a huge difference between a good stock, and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report: "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.
The article Ask a Fool: Is Gilead Sciences, Inc. a Sell? originally appeared on Fool.com.
David Williamson owns shares of AbbVie. Follow David on Twitter: @MotleyDavid.The Motley Fool recommends Gilead Sciences. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
